Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
162.00
-3.00 (-1.82%)
Oct 28, 2025, 2:38 PM CST
-1.82% (1Y)
| Market Cap | 255.92B |
| Revenue (ttm) | 44.83M |
| Net Income (ttm) | -618.09M |
| Shares Out | 1.55B |
| EPS (ttm) | -0.41 |
| PE Ratio | n/a |
| Forward PE | 72.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21,000 |
| Average Volume | 12,886,702 |
| Open | 165.50 |
| Previous Close | 165.00 |
| Day's Range | 161.50 - 166.00 |
| 52-Week Range | 47.45 - 277.00 |
| Beta | 0.88 |
| RSI | 41.29 |
| Earnings Date | Nov 7, 2025 |